Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Horizon Pharma Ord (HZNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,724,739
  • Shares Outstanding, K 167,630
  • Annual Sales, $ 1,056 M
  • Annual Income, $ -410,530 K
  • 36-Month Beta 1.29
  • Price/Sales 3.47
  • Price/Cash Flow 7.17
  • Price/Book 4.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.53
  • Number of Estimates 5
  • High Estimate 0.55
  • Low Estimate 0.48
  • Prior Year 0.29
  • Growth Rate Est. (year over year) +82.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.56 +34.18%
on 10/26/18
23.38 -4.96%
on 11/08/18
+3.15 (+16.52%)
since 10/19/18
3-Month
16.56 +34.18%
on 10/26/18
23.38 -4.96%
on 11/08/18
+1.65 (+8.02%)
since 08/17/18
52-Week
12.55 +77.05%
on 05/09/18
23.38 -4.96%
on 11/08/18
+8.57 (+62.78%)
since 11/17/17

Most Recent Stories

More News
Lannett Co Inc has the Best Relative Performance in the Pharmaceuticals Industry (LCI , COLL , HZNP , ZGNX , SUPN )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

COLL : 17.00 (-2.19%)
LCI : 6.19 (+3.69%)
HZNP : 22.22 (+1.65%)
Horizon Pharma plc to Participate in Upcoming Conferences

Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the following conferences:

HZNP : 22.22 (+1.65%)
Look for Shares of Horizon Pharma P to Potentially Rebound after Yesterday's 2.21% Sell Off

Horizon Pharma P (NASDAQ:HZNP) traded in a range yesterday that spanned from a low of $19.39 to a high of $21.00. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of...

HZNP : 22.22 (+1.65%)
Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise

Shares of Horizon Pharma (HZNP) rise almost 16%, owing to record quarterly sales during the third quarter of 2018.

HZNP : 22.22 (+1.65%)
MRK : 76.35 (+0.38%)
LLY : 115.81 (+1.74%)
BMY : 53.48 (-1.09%)
Clinical Study Advancements for New Cancer Drug Candidates Boosting Optimism in Oncology Therapy Industry

Financialnewsmedia.com News Commentary

CTMX : 13.29 (-8.09%)
HZNP : 22.22 (+1.65%)
LLY : 115.81 (+1.74%)
ABBV : 89.48 (-2.24%)
MBRX : 1.40 (+0.72%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (HZNP , SUPN , NKTR , ITCI , CTLT )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

HZNP : 22.22 (+1.65%)
SUPN : 42.31 (-3.69%)
NKTR : 38.01 (-0.58%)
Horizon Pharma (HZNP) Tops Q3 Earnings and Revenue Estimates

Horizon Pharma (HZNP) delivered earnings and revenue surprises of 30.00% and 3.39%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

HZNP : 22.22 (+1.65%)
Horizon Pharma plc Reports Third-Quarter Net Sales Growth of 20 Percent Driven by Orphan and Rheumatology Net Sales Growth of 25 Percent; Increases Full-Year 2018 Adjusted EBITDA Guidance

-- Quarterly Orphan and Rheumatology Segment Net Sales Increased 25 Percent to $219.9 Million; Represented 68 Percent of Total Company Net Sales --

HZNP : 22.22 (+1.65%)
Is A Disappointment in Store for Tilray (TLRY) Q3 Earnings?

Investors will focus on pipeline progress and updates when Tilray (TLRY) reports third-quarter results.

CRSP : 34.04 (-8.40%)
HZNP : 22.22 (+1.65%)
TLRY : 106.77 (-3.36%)
NVS : 88.31 (+0.64%)
Endo (ENDP) to Report Q3 Earnings: What's in the Cards?

Investors are expected to focus on the Xiaflex performance and pipeline updates when Endo (ENDP) reports third-quarter results.

CRSP : 34.04 (-8.40%)
ENDP : 12.46 (-1.81%)
HZNP : 22.22 (+1.65%)
MRK : 76.35 (+0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade HZNP with:

Business Summary

Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The company markets a portfolio of products in arthritis, inflammation and orphan diseases....

See More

Key Turning Points

2nd Resistance Point 22.66
1st Resistance Point 22.44
Last Price 22.22
1st Support Level 21.80
2nd Support Level 21.39

See More

52-Week High 23.38
Last Price 22.22
Fibonacci 61.8% 19.24
Fibonacci 50% 17.97
Fibonacci 38.2% 16.69
52-Week Low 12.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar